Century Therapeutics
IPSC
49 hedge funds and large institutions have $496M invested in Century Therapeutics in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 13 closing their positions.
100% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 13
36% more funds holding
Funds holding: 36 → 49 (+13)
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
5.61% more ownership
Funds ownership: 30.79% → 36.39% (+5.6%)
1% more capital invested
Capital invested by funds: $491M → $496M (+$5.38M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$86.6M |
| 2 |
BlackRock
New York
|
+$17.6M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$16.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$8.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
SB Management
Abu Dhabi,
United Arab Emirates
|
-$58.7M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$9.47M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$7.15M |
| 4 |
Millennium Management
New York
|
-$3.04M |
| 5 |
EP
Eversept Partners
New York
|
-$2.96M |
IPSC Hedge Fund Activity: Q3 2021 in Review
49 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Century Therapeutics (IPSC) for Q3 2021, worth a combined $496M — up 1.1% from $491M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new IPSC positions and 13 closed out — a net gain of 13 holders — while 9 added to existing stakes and 8 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $86.6M. The largest seller was SB Management, exiting entirely with an estimated $58.7M sold.
- 49 institutional investors held Century Therapeutics (IPSC) as of Q3 2021, up from 36 in Q2 2021.
- Funds reported $496M of Century Therapeutics stock for Q3 2021, up 1.1% quarter-over-quarter.
- 26 funds opened new Century Therapeutics positions in Q3 2021 and 13 closed out, a net change of +13 holders.
- The largest Century Therapeutics buyer in Q3 2021 was Fidelity Investments, an estimated $86.6M added.
- The largest Century Therapeutics seller in Q3 2021 was SB Management, an estimated $58.7M sold.
Based on aggregated 13F filings for Q3 2021.